Loading…

The change of antizyme inhibitor expression and its possible role during mammalian cell cycle

Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with th...

Full description

Saved in:
Bibliographic Details
Published in:Experimental cell research 2009-08, Vol.315 (13), p.2301-2311
Main Authors: Murakami, Yasuko, Suzuki, Jun-ichiro, Samejima, Keijiro, Kikuchi, Kenjiro, Hascilowicz, Tomasz, Murai, Noriyuki, Matsufuji, Senya, Oka, Takami
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3
cites cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3
container_end_page 2311
container_issue 13
container_start_page 2301
container_title Experimental cell research
container_volume 315
creator Murakami, Yasuko
Suzuki, Jun-ichiro
Samejima, Keijiro
Kikuchi, Kenjiro
Hascilowicz, Tomasz
Murai, Noriyuki
Matsufuji, Senya
Oka, Takami
description Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.
doi_str_mv 10.1016/j.yexcr.2009.04.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67371098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482709001955</els_id><sourcerecordid>20070115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</originalsourceid><addsrcrecordid>eNqFkcFrFDEUxoModm39CwQJHrzN9CWbTDIHD1KsCoVe6rGETPKmm2UmsyYzpetfb7a7IHjQHBJCfu_Le99HyDsGNQPWXG7rPT65VHOAtgZRAxcvyIpBCxUXnL8kKwAmKqG5OiNvct4CgNaseU3OWCt4o7hekfu7DVK3sfEB6dRTG-fwaz8iDXETujBPieLTLmHOYYrl1dMwZ7qbyr0bkKapbH5JIT7Q0Y6jHYKN1OEwULd3A16QV70dMr49nefkx_WXu6tv1c3t1-9Xn28qJ5icK-11w6zyUjCF3ksvVe_BlQWeobSd1ZL3XSs6y7teOoBeStk3TPXKd61bn5OPR91dmn4umGczhnxow0aclmwatVbFGP1fsHipgDFZwA9_gdtpSbEMYYp5jZa6XRdofYRcKo4k7M0uhdGmvWFgDhmZrXnO6KDbGhCmZFSq3p-kl25E_6fmFEoBPh0BLJY9Bkwmu4DRoQ8J3Wz8FP75wW_ImKT-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194685893</pqid></control><display><type>article</type><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><source>ScienceDirect Freedom Collection</source><creator>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</creator><creatorcontrib>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</creatorcontrib><description>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1016/j.yexcr.2009.04.024</identifier><identifier>PMID: 19426728</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Antizyme ; Antizyme inhibitor ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Cell culture ; Cell cycle ; Cell Cycle - drug effects ; Cell Cycle - physiology ; Cell division ; Cell Line, Tumor ; Cell-Free System ; Centrosome ; Cytokinesis ; Eflornithine - metabolism ; Enzyme Stability ; Inhibitor drugs ; Mammals ; Nocodazole - pharmacology ; ODC ; Ornithine Decarboxylase - metabolism ; Ornithine Decarboxylase Inhibitors ; Polyamines - metabolism ; Proteins - metabolism ; Rats ; RNA, Messenger - metabolism ; RNA, Small Interfering - genetics ; RNA, Small Interfering - metabolism</subject><ispartof>Experimental cell research, 2009-08, Vol.315 (13), p.2301-2311</ispartof><rights>2009 Elsevier Inc.</rights><rights>Copyright © 2009 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</citedby><cites>FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19426728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murakami, Yasuko</creatorcontrib><creatorcontrib>Suzuki, Jun-ichiro</creatorcontrib><creatorcontrib>Samejima, Keijiro</creatorcontrib><creatorcontrib>Kikuchi, Kenjiro</creatorcontrib><creatorcontrib>Hascilowicz, Tomasz</creatorcontrib><creatorcontrib>Murai, Noriyuki</creatorcontrib><creatorcontrib>Matsufuji, Senya</creatorcontrib><creatorcontrib>Oka, Takami</creatorcontrib><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antizyme</subject><subject>Antizyme inhibitor</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell culture</subject><subject>Cell cycle</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Cycle - physiology</subject><subject>Cell division</subject><subject>Cell Line, Tumor</subject><subject>Cell-Free System</subject><subject>Centrosome</subject><subject>Cytokinesis</subject><subject>Eflornithine - metabolism</subject><subject>Enzyme Stability</subject><subject>Inhibitor drugs</subject><subject>Mammals</subject><subject>Nocodazole - pharmacology</subject><subject>ODC</subject><subject>Ornithine Decarboxylase - metabolism</subject><subject>Ornithine Decarboxylase Inhibitors</subject><subject>Polyamines - metabolism</subject><subject>Proteins - metabolism</subject><subject>Rats</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>RNA, Small Interfering - metabolism</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkcFrFDEUxoModm39CwQJHrzN9CWbTDIHD1KsCoVe6rGETPKmm2UmsyYzpetfb7a7IHjQHBJCfu_Le99HyDsGNQPWXG7rPT65VHOAtgZRAxcvyIpBCxUXnL8kKwAmKqG5OiNvct4CgNaseU3OWCt4o7hekfu7DVK3sfEB6dRTG-fwaz8iDXETujBPieLTLmHOYYrl1dMwZ7qbyr0bkKapbH5JIT7Q0Y6jHYKN1OEwULd3A16QV70dMr49nefkx_WXu6tv1c3t1-9Xn28qJ5icK-11w6zyUjCF3ksvVe_BlQWeobSd1ZL3XSs6y7teOoBeStk3TPXKd61bn5OPR91dmn4umGczhnxow0aclmwatVbFGP1fsHipgDFZwA9_gdtpSbEMYYp5jZa6XRdofYRcKo4k7M0uhdGmvWFgDhmZrXnO6KDbGhCmZFSq3p-kl25E_6fmFEoBPh0BLJY9Bkwmu4DRoQ8J3Wz8FP75wW_ImKT-</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Murakami, Yasuko</creator><creator>Suzuki, Jun-ichiro</creator><creator>Samejima, Keijiro</creator><creator>Kikuchi, Kenjiro</creator><creator>Hascilowicz, Tomasz</creator><creator>Murai, Noriyuki</creator><creator>Matsufuji, Senya</creator><creator>Oka, Takami</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</title><author>Murakami, Yasuko ; Suzuki, Jun-ichiro ; Samejima, Keijiro ; Kikuchi, Kenjiro ; Hascilowicz, Tomasz ; Murai, Noriyuki ; Matsufuji, Senya ; Oka, Takami</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antizyme</topic><topic>Antizyme inhibitor</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell culture</topic><topic>Cell cycle</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Cycle - physiology</topic><topic>Cell division</topic><topic>Cell Line, Tumor</topic><topic>Cell-Free System</topic><topic>Centrosome</topic><topic>Cytokinesis</topic><topic>Eflornithine - metabolism</topic><topic>Enzyme Stability</topic><topic>Inhibitor drugs</topic><topic>Mammals</topic><topic>Nocodazole - pharmacology</topic><topic>ODC</topic><topic>Ornithine Decarboxylase - metabolism</topic><topic>Ornithine Decarboxylase Inhibitors</topic><topic>Polyamines - metabolism</topic><topic>Proteins - metabolism</topic><topic>Rats</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>RNA, Small Interfering - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murakami, Yasuko</creatorcontrib><creatorcontrib>Suzuki, Jun-ichiro</creatorcontrib><creatorcontrib>Samejima, Keijiro</creatorcontrib><creatorcontrib>Kikuchi, Kenjiro</creatorcontrib><creatorcontrib>Hascilowicz, Tomasz</creatorcontrib><creatorcontrib>Murai, Noriyuki</creatorcontrib><creatorcontrib>Matsufuji, Senya</creatorcontrib><creatorcontrib>Oka, Takami</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murakami, Yasuko</au><au>Suzuki, Jun-ichiro</au><au>Samejima, Keijiro</au><au>Kikuchi, Kenjiro</au><au>Hascilowicz, Tomasz</au><au>Murai, Noriyuki</au><au>Matsufuji, Senya</au><au>Oka, Takami</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The change of antizyme inhibitor expression and its possible role during mammalian cell cycle</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>315</volume><issue>13</issue><spage>2301</spage><epage>2311</epage><pages>2301-2311</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>Antizyme inhibitor (AIn), a homolog of ODC, binds to antizyme and inactivates it. We report here that AIn increased at the G1 phase of the cell cycle, preceding the peak of ODC activity in HTC cells in culture. During interphase AIn was present mainly in the cytoplasm and turned over rapidly with the half-life of 10 to 20 min, while antizyme was localized in the nucleus. The level of AIn increased again at the G2/M phase along with ODC, and the rate of turn-over of AIn in mitotic cells decreased with the half-life of approximately 40 min. AIn was colocalized with antizyme at centrosomes during the period from prophase through late anaphase and at the midzone/midbody during telophase. Thereafter, AIn and antizyme were separated and present at different regions on the midbody at late telophase. AIn disappeared at late cytokinesis, whereas antizyme remained at the cytokinesis remnant. Reduction of AIn by RNA interference caused the increase in the number of binucleated cells in HTC cells in culture. These findings suggested that AIn contributed to a rapid increase in ODC at the G1 phase and also played a role in facilitating cells to complete mitosis during the cell cycle.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19426728</pmid><doi>10.1016/j.yexcr.2009.04.024</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 2009-08, Vol.315 (13), p.2301-2311
issn 0014-4827
1090-2422
language eng
recordid cdi_proquest_miscellaneous_67371098
source ScienceDirect Freedom Collection
subjects Animals
Antineoplastic Agents - pharmacology
Antizyme
Antizyme inhibitor
Carrier Proteins - genetics
Carrier Proteins - metabolism
Cell culture
Cell cycle
Cell Cycle - drug effects
Cell Cycle - physiology
Cell division
Cell Line, Tumor
Cell-Free System
Centrosome
Cytokinesis
Eflornithine - metabolism
Enzyme Stability
Inhibitor drugs
Mammals
Nocodazole - pharmacology
ODC
Ornithine Decarboxylase - metabolism
Ornithine Decarboxylase Inhibitors
Polyamines - metabolism
Proteins - metabolism
Rats
RNA, Messenger - metabolism
RNA, Small Interfering - genetics
RNA, Small Interfering - metabolism
title The change of antizyme inhibitor expression and its possible role during mammalian cell cycle
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A08%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20change%20of%20antizyme%20inhibitor%20expression%20and%20its%20possible%20role%20during%20mammalian%20cell%20cycle&rft.jtitle=Experimental%20cell%20research&rft.au=Murakami,%20Yasuko&rft.date=2009-08-01&rft.volume=315&rft.issue=13&rft.spage=2301&rft.epage=2311&rft.pages=2301-2311&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1016/j.yexcr.2009.04.024&rft_dat=%3Cproquest_cross%3E20070115%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-8d861a7d5417edd5d57fd0cccc0d1e5aba852fb94ba2bf5c00f555f617f7db9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=194685893&rft_id=info:pmid/19426728&rfr_iscdi=true